Year-to-date, pharma giant Johnson & Johnson (NYSE:JNJ) stock, a Dow Jones component, is down about 6%. By comparison, the Dow Jones as a whole is down about 17%.Source: Alexander Tolstykh / Shutterstock.com Given the market uncertainty over the COVID-19 pandemic, investors are understandably cautious about the outlook for many shares, including JNJ stock.I enjoy reading about the history of markets, including bull and bear markets and recessions. And a brief glance at history shows that Johnson & Johnson has been one of the steady performers in every economic cycle. Therefore, I expect management to continue the tradition and find ways for the company to grow earnings in the long-run.InvestorPlace – Stock Market News, Stock Advice & Trading Tips * 7 Penny Stocks To Buy with